Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Mine Safety
MSA
$7.33B
| $8.9M | 0.01% |
70,400
+1,300
| +2% | +$156K |
|
827
Acadia Pharmaceuticals
ACAD
$4.92B
| $8.88M | 0.01% |
207,504
+4,100
| +2% | +$178K |
|
828
Ashland
ASH
$3.38B
| $8.87M | 0.01% |
115,900
-2,100
| -2% | -$159K |
|
829
Darling Ingredients
DAR
$10.2B
| $8.85M | 0.01% |
315,300
+5,300
| +2% | +$118K |
|
830
Grand Canyon Education
LOPE
$3.79B
| $8.85M | 0.01% |
92,400
+1,500
| +2% | +$138K |
|
831
RB Global
RBA
$16B
| $8.85M | 0.01% |
206,500
| – | – |
|
832
Methanex
MEOH
$4.19B
| $8.78M | 0.01% |
227,500
-14,600
| -6% | -$548K |
|
833
Credit Acceptance
CACC
$6.08B
| $8.75M | 0.01% |
19,777
+300
| +2% | +$132K |
|
834
Pinterest
PINS
$13.3B
| $8.72M | 0.01% |
+467,700
| New | +$10.1M |
|
835
Clean Harbors
CLH
$16.8B
| $8.71M | 0.01% |
101,600
+1,700
| +2% | +$138K |
|
836
Brink's
BCO
$4.71B
| $8.68M | 0.01% |
95,700
+1,800
| +2% | +$159K |
|
837
Saic
SAIC
$5.38B
| $8.67M | 0.01% |
99,615
-700
| -0.7% | -$58.5K |
|
838
Madison Square Garden
MSGS
$10.1B
| $8.66M | 0.01% |
41,265
+701
| +2% | +$138K |
|
|
PACW
839
DELISTED
PacWest Bancorp
PACW
| $8.66M | 0.01% |
226,273
+2,600
| +1% | +$97.8K |
|
840
Landstar System
LSTR
$6.41B
| $8.64M | 0.01% |
75,900
+300
| +0.4% | +$33.9K |
|
841
Globus Medical
GMED
$11.5B
| $8.64M | 0.01% |
146,700
+2,700
| +2% | +$147K |
|
842
Helen of Troy
HELE
$696M
| $8.63M | 0.01% |
48,000
+1,000
| +2% | +$160K |
|
843
Westlake Corp
WLK
$10.2B
| $8.6M | 0.01% |
122,616
-6,300
| -5% | -$423K |
|
844
Dolby
DLB
$5.79B
| $8.5M | 0.01% |
123,500
+2,600
| +2% | +$172K |
|
|
SRC
845
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $8.48M | 0.01% |
172,454
-13,500
| -7% | -$671K |
|
846
ACI Worldwide
ACIW
$5.35B
| $8.47M | 0.01% |
223,500
+15,500
| +7% | +$528K |
|
847
First Solar
FSLR
$24.2B
| $8.47M | 0.01% |
151,300
+2,600
| +2% | +$143K |
|
848
Valley National Bancorp
VLY
$8.28B
| $8.46M | 0.01% |
739,260
+115,060
| +18% | +$1.32M |
|
849
ScottsMiracle-Gro
SMG
$3.6B
| $8.46M | 0.01% |
79,700
+1,400
| +2% | +$143K |
|
850
Avnet
AVT
$7.91B
| $8.41M | 0.01% |
198,300
-1,700
| -0.9% | -$70K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.